CHINA BIOLOGIC PRODUCTS, INC. 3,870,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2016 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
Certain stockholders (the “Selling Stockholders”) of China Biologic Products, Inc., a Delaware corporation (the “Company”) named in Schedule II hereto, the Company and the underwriter named in Schedule I hereto (the “Underwriter”) entered into an underwriting agreement dated March 1, 2016 (the “Prior Agreement”) in connection with sales of 3,500,000 shares of common stock of the Company, par value $0.0001 per share. The Company, the Selling Stockholders and the Underwriter hereby agree that the Prior Agreement shall be amended and restated in its entirety by this Agreement and further agree as follows.
CHINA BIOLOGIC PRODUCTS, INC. 3,500,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTChina Biologic Products • March 4th, 2016 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
Certain stockholders (the “Selling Stockholders”) of China Biologic Products, Inc., a Delaware corporation (the “Company”) named in Schedule II hereto severally and not jointly propose to sell to the underwriter named in Schedule I hereto (the “Underwriter”), an aggregate of 3,500,000 shares of common stock of the Company, par value $0.0001 per share (the “Shares”). The shares of common stock of the Company, par value $0.0001 per share, to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”
